Federation des caisses Desjardins du Quebec
XERS icon

Federation des caisses Desjardins du Quebec’s Xeris Biopharma Holdings XERS Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.9K Hold
1,500
– – ﹤0.01% 2363
2026
Q1 		$8.7K Buy
+1,500
New +$9.95K ﹤0.01% 2367
2024
Q2 		– Sell
-570
Closed -$1.26K – 2580
2024
Q1 		$1.26K Hold
570
– – ﹤0.01% 2173
2023
Q4 		$1.34K Buy
+570
New +$1.05K ﹤0.01% 2123
2022
Q2 		– Sell
-300
Closed -$768 – 2604
2022
Q1 		$768 Buy
+300
New +$733 ﹤0.01% 2453

Other funds holding XERS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's XERS Position: Q2 2026 in Review

Federation des caisses Desjardins du Quebec held its Xeris Biopharma Holdings (XERS) position steady in Q2 2026 at 1,500 shares worth $11.9K. The position accounts for ﹤0.01% of the portfolio, ranked #2363.

Federation des caisses Desjardins du Quebec first reported a position in XERS in Q1 2022 and has held it in 5 quarters since. 240 funds tracked by Wall St. Rank hold XERS as of Q2 2026.

  • Federation des caisses Desjardins du Quebec held 1,500 shares of Xeris Biopharma Holdings worth $11.9K as of Q2 2026.
  • Federation des caisses Desjardins du Quebec left its Xeris Biopharma Holdings share count unchanged in Q2 2026.
  • Xeris Biopharma Holdings made up ﹤0.01% of Federation des caisses Desjardins du Quebec's portfolio in Q2 2026, its #2363 holding.
  • Federation des caisses Desjardins du Quebec first reported a position in Xeris Biopharma Holdings in Q1 2022 and has held it in 5 quarters since.
  • 240 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q2 2026.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q2 2026, filed 14 Aug 2026.